News
The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...
FDA Commissioner Marty Makary last week announced a directive that would limit industry participation in the agency’s ...
We rely on volunteers to bring their diverse backgrounds and expertise to participate on these boards and committees. Advisory committees, local boards, agencies, commissions and associations help the ...
The U.S. Food and Drug Administration (FDA) has announced a new policy directive to limit employees of FDA-regulated ...
Months after policy freeze, the DTAB is reconstituted to take up pending issues like AMR, GMP, spurious drugs and ...
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Vlad Coric, M.D. to the company’s Board of Directors, effective immediately. Vlad ...
Dataphyte is expanding its Editorial Advisory Board to reflect the group’s growth as a socioeconomic think tank for health, education, economy, etc. The new board fields 13 individuals with rich ...
April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC ... Following this decision, the Company's board of directors has authorized management to initiate wind-down activities and ...
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & ...
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Vlad Coric, M.D. to the company’s Board of Directors, effective immediately.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results